Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease
Abstract The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson’s disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic m...
Main Authors: | Tereza Tykalova, Michal Novotny, Evzen Ruzicka, Petr Dusek, Jan Rusz |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-022-00286-y |
Similar Items
-
Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
by: Jan Rusz, et al.
Published: (2021-11-01) -
Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
by: Michal Novotny, et al.
Published: (2022-07-01) -
Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson’s disease
by: Dominik Skrabal, et al.
Published: (2022-10-01) -
Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
by: Khalid Daoudi, et al.
Published: (2022-10-01) -
Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease
by: Michal Novotný, et al.
Published: (2016-09-01)